Inventor · disambiguated record
David Eveleth
Also filed as: EVELETH DAVID · EVELETH DAVID D · EVELETH JR DAVID D
7 granted patents·6 pending applications·226 citations·filing 1990–2024
85Inventor score
Files withTREFOIL THERAPEUTICS INC6CORTEX PHARMA INC2CORTEX PHARMACEUTICALS1E&B TECH LLC1UNIV CALIFORNIA1
Top patents by PatentIndex Score
13 records- 0192US5567724AAlkaline and acid phosphatase inhibitors in treatment of neurological disordersCORTEX PHARMA INC·Filed 1994·Granted Oct 22, 1996·118 cites·19 claims
- 0276US5118606AMethods for detecting cellular pathology by assaying spectrin and spectrin breakdown productsUNIV CALIFORNIA·Filed 1990·Granted Jun 2, 1992·43 cites·35 claims
- 0375US11103553B2Modified fibroblast growth factors for the treatment of ocular disordersTREFOIL THERAPEUTICS INC·Filed 2014·Granted Aug 31, 2021·2 cites·5 claims
- 0469US5444042AMethod of treatment of neurodegeneration with calpain inhibitorsCORTEX PHARMACEUTICALS·Filed 1994·Granted Aug 22, 1995·52 cites·35 claims
- 0562US2025066440A1Methods of treatment using modified fgf-1 polypeptidesTREFOIL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0660US2021338777A1Modified fibroblast growth factors for the treatment of ocular disordersTREFOIL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0757US10537607B2Treatment of autoimmune and/or inflammatory disease using novel caveolin modulatorsE&B TECH LLC·Filed 2014·Granted Jan 21, 2020·0 cites·6 claims
- 0857US2024024421A1Recombinant modified fibroblast growth factors and therapeutic uses thereofTREFOIL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0948US5622981AUse of metabotropic receptor agonists in progressive neurodegenerative diseasesCORTEX PHARMA INC·Filed 1995·Granted Apr 22, 1997·11 cites·18 claims
- 1044US2004058926A1Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disordersFiled 2001·Application pending·0 cites
- 1137US2002128267A1Method of using COX-2 inhibitors in the treatment and prevention of ocular COX-2 mediated disordersFiled 2001·Application pending·0 cites
- 1236US2021009650A1Modified fibroblast growth factors and uses thereofTREFOIL THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1331US11479591B2Recombinant modified fibroblast growth factors and therapeutic uses thereofTREFOIL THERAPEUTICS INC·Filed 2018·Granted Oct 25, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when David Eveleth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →